文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

爱尔兰急性医院社区获得性与医院获得性脓毒症的流行病学,2016-2022年

Epidemiology of Community-Acquired Versus Hospital-Acquired Sepsis in Acute Hospitals in Ireland, 2016-2022.
PubMed 文献 · Crit Care Explor · 2025-07-15
一句话结论爱尔兰2016-2022年回顾性队列显示医院获得性脓毒症占14.8%,其院内死亡风险为社区获得性的1.5倍。

该回顾性队列研究纳入爱尔兰所有急性公立医院2016-2022年HIPE系统中带脓毒症诊断编码的出院记录,比较社区获得性与医院获得性脓毒症事件及其与脓毒症相关死亡的关系。数据库中社区获得性脓毒症事件为86,011例(85.2%),医院获得性为14,930例(14.8%)。医院获得性脓毒症患者院内死亡的可能性是社区获得性的1.5倍。分析的诊断中,SARS-CoV-2是预测死亡最强的危险因素(OR=2.4),其次为心脏病(OR=1.9)和流感或肺炎(OR=1.9);社会经济地位较低的脓毒症患者死亡可能性高20%。

要点

  • 医院获得性脓毒症患者院内死亡可能性是社区获得性脓毒症患者的1.5倍。
  • 数据库中社区获得性脓毒症事件86,011例(85.2%),医院获得性脓毒症事件14,930例(14.8%)。
  • SARS-CoV-2是预测脓毒症死亡最强的危险因素(OR=2.4),其次为心脏病(OR=1.9)和流感或肺炎(OR=1.9)。
  • 社会经济地位较低的脓毒症患者死亡可能性高20%。
  • 作者认为医院获得性感染所致脓毒症及SARS-CoV-2、流感或肺炎、癌症、心脏病等关键感染类型和合并症与脓毒症相关死亡风险显著增加有关。

适用人群与场景

  • 2016-2022年爱尔兰所有急性公立医院出院记录中带有脓毒症相关诊断编码的患者(数据来自医院住院患者调查系统)。

研究设计与关键结果

  • 研究类型为回顾性队列研究,数据来自爱尔兰所有急性公立医院2016-2022年医院住院患者调查系统,纳入带脓毒症相关诊断编码的出院记录。
  • 社区获得性脓毒症事件86,011例(85.2%),医院获得性脓毒症事件14,930例(14.8%)。
  • 医院获得性脓毒症患者院内死亡可能性是社区获得性脓毒症患者的1.5倍。
  • 分析的诊断中,SARS-CoV-2是预测死亡最强的危险因素(OR=2.4),其次为心脏病(OR=1.9)和流感或肺炎(OR=1.9)。
  • 社会经济地位较低的脓毒症患者死亡可能性高20%。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为医院获得性感染所致脓毒症患者及合并SARS-CoV-2、流感或肺炎、癌症、心脏病的脓毒症患者脓毒症相关死亡风险显著增加。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Sepsis is a leading cause of morbidity and mortality. Understanding sepsis epidemiology is crucial to enable clinicians to identify patients at highest risk of developing and dying from sepsis.

OBJECTIVES: While community-acquired (CA) sepsis has been identified as more common than hospital-acquired (HA) sepsis, HA sepsis has led to increased morbidity and mortality. Few studies, however, have analyzed CA and HA sepsis by site of infection or by patient comorbidities. The aim of this analysis was to describe the epidemiology of patients with CA and HA sepsis diagnosed in Ireland.

DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective cohort study. The setting was all Irish acute public hospitals from 2016 to 2022. Data were extracted from the Hospital In-Patient Enquiry (HIPE) system recording all discharges from acute public hospitals, if a sepsis-related diagnostic code was included.

MAIN OUTCOMES AND MEASURES: Univariate and multivariate analysis was conducted to compare CA and HA sepsis events and their association with sepsis-associated mortality.

RESULTS: The number of CA vs. HA sepsis events in the database was 86,011 (85.2%) vs. 14,930 (14.8%). HA sepsis patients were 1.5 times more likely to die in hospital compared with CA. Of diagnoses analyzed, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the strongest risk factor predictive of mortality (odds ratio [OR] = 2.4) followed by cardiac disease (OR, 1.9) and influenza or pneumonia (OR, 1.9). Sepsis patients with a lower socioeconomic status had a 20% higher likelihood of death.

CONCLUSIONS AND RELEVANCE: This analysis highlighted a significant increased risk of sepsis-associated mortality for patients diagnosed with sepsis as a result of a HA infection and key infection types and comorbidities including SARS-CoV-2, influenza or pneumonia, cancer, and cardiac disease.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Liddy EM, Amin DK, McKeown DJ, et al. Epidemiology of Community-Acquired Versus Hospital-Acquired Sepsis in Acute Hospitals in Ireland, 2016-2022. Crit Care Explor. 2025. PMID: 40663158. doi:10.1097/CCE.0000000000001289

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。